| Company Name: |
Shanghai Synteam Biochem CO.,ltd
|
| Tel: |
+86-021-58380978 13482386415 |
| Email: |
info@systeambc.com |
| Products Intro: |
Product Name:3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-amine CAS:116233-17-1 Purity:98% Package:1kg;10kg
|
| Company Name: |
BePharm Ltd
|
| Tel: |
400-685-9117 |
| Email: |
market@bepharm.com |
| Products Intro: |
Product Name:3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-amine CAS:116233-17-1 Purity:98% Package:5542RMB/1g
|
|
| | 5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenamine Basic information |
| Product Name: | 5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenamine | | Synonyms: | 5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenamine;2-Naphthalenamine, 5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-;3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-amine | | CAS: | 116233-17-1 | | MF: | C15H23N | | MW: | 217.35 | | EINECS: | 1806241-263-5 | | Product Categories: | | | Mol File: | 116233-17-1.mol |  |
| | 5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenamine Chemical Properties |
| Melting point | 96-97 °C | | Boiling point | 321.2±31.0 °C(Predicted) | | density | 0.938±0.06 g/cm3(Predicted) | | storage temp. | Keep in dark place,Inert atmosphere,Room temperature | | pka | 5.01±0.60(Predicted) |
| | 5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenamine Usage And Synthesis |
| Synthesis | 3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-amine (6) was synthesized as follows: 1,1,4,4,6-pentamethyl-7-nitro-1,2,3,4-tetrahydronaphthalene (5) (2.5 g, 10.1 mmol) was dissolved in ethyl acetate (205 mL) to prepare a 0.05 M solution. The hydrogenation reaction was repeated twice using a ThalesNano H-cubereactor at 70°C and 2-5 bar pressure through a 10 mL Pd/C cartridge at a flow rate of 1.0 mL/min. Upon completion of the reaction, the resulting solution was concentrated under vacuum to afford the target product 6 (2.13 g, 97% yield) as a yellow crystalline solid with a melting point of 205°C. The structure of the product was confirmed by the following characterization data: 1H NMR (400 MHz, CDCl3) δ 7.00 (s, 1H), 6.63 (s, 1H), 3.34 (br s, 2H), 2.15 (s, 3H), 1.63 (s, 4H), 1.26 (s, 12H); 13C NMR (100.6 MHz, CDCl3) δ 143.5, 142.0, 135.2, 128.3, 120.5, 112.6, 35.3, 35.2, 33.8, 33.4, 32.0, 31.8, 17.1; IR ( neat)ν 3404, 3335, 2956, 2925, 1626, 1504 cm-1; LC-MS-CI (M+H)+ calculated value C15H24N 218.1909, measured value 218.1908. | | References | [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 9, p. 2352 - 2356 [2] Patent: WO2015/130973, 2015, A1. Location in patent: Page/Page column 20; 21 [3] Journal of Medicinal Chemistry, 2016, vol. 59, # 19, p. 8924 - 8940 [4] Patent: US2018/207156, 2018, A1. Location in patent: Paragraph 0114; 0131 [5] Journal of Medicinal Chemistry, 1989, vol. 32, # 7, p. 1504 - 1517 |
| | 5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenamine Preparation Products And Raw materials |
|